The following piece of info will give more weight to my argument that GSK is probably going to increase production rates again. GSK needs the extra money to keep their profits up. Relenza with has already many orders booked in advance would be a fairly safe and cheap way to get that extra money in fast for the next couple of years.
jojo
Analysts note that the pandemic couldn’t have come at a better time for Glaxo, one of the world’s largest vaccine makers. Generics have been steadily eating into the company’s margins, leaving Glaxo looking for new products to make up the shortfall.
BTA Price at posting:
$1.88 Sentiment: LT Buy Disclosure: Held